Compounds > thiazoles
Page last updated: 2024-08-21

thiazoles and Polycythemia Vera

thiazoles has been researched along with Polycythemia Vera in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albizua, E; Arenas, A; Ayala, R; Barrio, S; Burgaleta, C; Gallardo, M; Gilsanz, F; Jiménez-Ubieto, A; Martinez-Lopez, J; Rapado, I; Rueda, D1
Kurosu, T; Miura, O; Nagao, T; Nogami, A; Oshikawa, G; Tohda, S; Umezawa, Y; Yamamoto, M1
Handa, H; Ishizaki, T; Koiso, H; Mitsui, T; Murakami, H; Nojima, Y; Ogawa, Y; Saitoh, T; Sekigami, T; Takizawa, M; Tsukamoto, N; Yokohama, A1
Gisslinger, H; Jaeger, E; Oehler, L; Schwarzinger, I; Streubel, B; Valent, P; Wappl, M1
Bolton, E; Cerny-Reiterer, S; Cramer, K; Dorrance, A; Eaves, CJ; Flis, S; Glodkowska-Mrowka, E; Hochhaus, A; Holyoake, TL; Hoser, G; Hughes, TP; Kopinski, PK; Koptyra, M; Ngaba, D; Nieborowska-Skorska, M; Penserga, T; Ray, R; Reddy, MM; Richardson, C; Sattler, M; Skorski, T; Stoklosa, T; Valent, P; van der Kuip, H; Wiktor-Jedrzejczak, W; Williams, DA1
Demidova, AV; Kozlova, AF; Shcherbak, EM1
Krasiukova, LI; Nikolaeva, NV; Osechenskaia, GV; Protasova, TG1

Other Studies

7 other study(ies) available for thiazoles and Polycythemia Vera

ArticleYear
Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm.
    British journal of haematology, 2013, Volume: 161, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cell Proliferation; Cells, Cultured; Chronic Disease; Dasatinib; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Female; Humans; Janus Kinase 2; Janus Kinases; Male; Middle Aged; Myeloproliferative Disorders; Niacinamide; Nitriles; Phenylurea Compounds; Phosphorylcholine; Polycythemia Vera; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrrolidinones; Signal Transduction; Sorafenib; STAT5 Transcription Factor; Thiazoles; Thrombocythemia, Essential; Tumor Cells, Cultured

2013
Proliferation and survival signaling from both Jak2-V617F and Lyn involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 cell line newly established from acute myeloid leukemia transformed from polycythemia vera.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Bone Marrow; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Dasatinib; DNA Mutational Analysis; Female; Glycogen Synthase Kinase 3; Humans; Janus Kinase 2; Karyotype; Leukemia, Myeloid, Acute; Middle Aged; Mutation; Phosphoproteins; Phosphorylation; Polycythemia Vera; Protein Kinase Inhibitors; Pyrimidines; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; src-Family Kinases; Thiazoles

2014
[Successful treatment with dasatinib for polycythemia vera patient emerging BCR-ABL positive clone during 13 years of treatment].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:6

    Topics: Dasatinib; Female; Fusion Proteins, bcr-abl; Humans; Janus Kinase 2; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Mutation; Polycythemia Vera; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Time Factors

2014
Dasatinib inhibits progenitor cell proliferation from polycythaemia vera.
    European journal of clinical investigation, 2008, Volume: 38, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Cell Proliferation; Cells, Cultured; Dasatinib; Dose-Response Relationship, Drug; Erythroid Precursor Cells; Female; Humans; Janus Kinase 2; Male; Middle Aged; Myeloid Progenitor Cells; Polycythemia Vera; Protein Kinase Inhibitors; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles

2008
Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors.
    Blood, 2012, May-03, Volume: 119, Issue:18

    Topics: Animals; Catalase; Disease Progression; DNA Damage; DNA, Neoplasm; Electron Transport; Electron Transport Complex III; Fusion Proteins, bcr-abl; Genomic Instability; Humans; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic-Phase; Membrane Potential, Mitochondrial; Methacrylates; Mice; Neoplasm Proteins; Neoplastic Stem Cells; Polycythemia Vera; rac GTP-Binding Proteins; RAC2 GTP-Binding Protein; Reactive Oxygen Species; Recombinant Fusion Proteins; Superoxide Dismutase; Thiazoles

2012
[Treatment of erythremia with imifos (10-year experience with hospital and ambulatory treatment of patients)].
    Terapevticheskii arkhiv, 1975, Volume: 47, Issue:1

    Topics: Adult; Ambulatory Care; Antineoplastic Agents; Azirines; Blood Cell Count; Bloodletting; Hospitalization; Humans; Organophosphorus Compounds; Polycythemia; Polycythemia Vera; Remission, Spontaneous; Thiazoles; Time Factors

1975
[Use of imiphos and myelobromol in erythremias under polyclinic conditions].
    Problemy gematologii i perelivaniia krovi, 1972, Volume: 17, Issue:10

    Topics: Ambulatory Care; Azirines; Blood; Bromine; Chronic Disease; Humans; Mannitol; Organophosphorus Compounds; Polycythemia Vera; Remission, Spontaneous; Thiazoles

1972